Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial.

Lacabaratz C, Durand M, Wiedemann A, Foucat E, Surénaud M, Krief C, Guillaumat L, Robinson C, Luhn K, Bockstal V, Thiébaut R, Richert L, Lévy Y

Open source

DOI: 10.1093/infdis/jiae360
Published: 2025 Feb 4
Container: The Journal of infectious diseases
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/infdis/jiae360,
  title = {Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial.},
  author = {Lacabaratz C and Durand M and Wiedemann A and Foucat E and Surénaud M and Krief C and Guillaumat L and Robinson C and Luhn K and Bockstal V and Thiébaut R and Richert L and Lévy Y},
  year = {2025},
  journal = {The Journal of infectious diseases},
  doi = {10.1093/infdis/jiae360},
  url = {https://doi.org/10.1093/infdis/jiae360}
}

RIS

TY  - JOUR
TI  - Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial.
AU  - Lacabaratz C
AU  - Durand M
AU  - Wiedemann A
AU  - Foucat E
AU  - Surénaud M
AU  - Krief C
AU  - Guillaumat L
AU  - Robinson C
AU  - Luhn K
AU  - Bockstal V
AU  - Thiébaut R
AU  - Richert L
AU  - Lévy Y
PY  - 2025
JO  - The Journal of infectious diseases
DO  - 10.1093/infdis/jiae360
UR  - https://doi.org/10.1093/infdis/jiae360
ER  -

APA

C, L., M, D., A, W., E, F., M, S., C, K., L, G., C, R., K, L., V, B., R, T., L, R., & Y, L. (2025). Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial.. The Journal of infectious diseases. https://doi.org/10.1093/infdis/jiae360

Source records

pubmed · retrieved 2026-09-27T08:32:11.358Z